What is the main goal of treatment in patients with heart failure and preserved ejection fraction (HFpEF)?

The primary goal of treatment in patients with heart failure and preserved ejection fraction (HFpEF) focuses on improving fluid management and reducing symptoms. In HFpEF, the heart maintains its ability to pump blood effectively, but there is often an issue with the heart's filling capacity, leading to symptoms such as shortness of breath, fatigue, and fluid retention.

Effective management of HFpEF centers on relieving these symptoms by addressing fluid overload, which often manifests as edema or pulmonary congestion. This is typically achieved through diuretics, lifestyle modifications, and evaluating comorbidities such as hypertension and diabetes. The aim is to enhance the patient's quality of life and minimize hospitalizations related to heart failure exacerbations.

The other options, while they might contain elements that seem relevant, do not represent the main focus of treatment for HFpEF. For instance, while controlling blood pressure is important, it is not the only goal, nor is it the primary focus. Similarly, increasing heart rate or promoting weight gain does not align with the management objectives for this patient population. Thus, the emphasis on fluid management and symptom reduction is key in the therapeutic approach to HFpEF.